Ghatnekar, O., Hjalte, F. and Taylor, M. (2010) “Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib – a Swedish model application”, Acta Oncologica, 49(6), pp. 851–858. doi: 10.3109/0284186X.2010.495132.